A comparison of reweighting estimators of average treatment effects in real world populations

Chen-Yen Lin1, Eloise Kaizar2, Douglas Faries1

  • 1Eli Lilly and Company, Indianapolis, Indiana, USA.

Insights

Statistical methods can generalize randomized controlled trial (RCT) findings to real-world populations by weighting trial participants. The best approach depends on population characteristics and selection bias.

Area of Science:

  • Biostatistics
  • Health Services Research
  • Clinical Trial Methodology

Background:

  • Regulatory agencies approve interventions based on randomized controlled trials (RCTs).
  • Healthcare stakeholders need real-world effectiveness data beyond idealized RCT settings.
  • Real-world effectiveness evidence is typically unavailable at the time of initial approval.

Purpose of the Study:

  • To evaluate statistical methods for generalizing RCT treatment effects to target populations.
  • To identify optimal estimation and weight construction procedures for real-world effectiveness.

Main Methods:

  • Utilized weighting procedures to adjust RCT participant data.
  • Compared various estimation and weight construction methods.
  • Employed simulations and a real-world Alzheimer's disease clinical trial dataset.

Main Results:

  • The optimal statistical approach for generalizing RCT results is contingent upon population characteristics.
  • Factors influencing the best method include selection bias and treatment effect heterogeneity.
  • Demonstrated the application using a real-world Alzheimer's disease intervention study.

Conclusions:

  • Statistical generalization methods can bridge the gap between RCT efficacy and real-world effectiveness.
  • Careful consideration of source and target population attributes is crucial for accurate estimation.
  • Provides guidance for stakeholders seeking to understand intervention performance in diverse populations.

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.6K
Weighted Mean00:57

Weighted Mean

While taking the arithmetic, geometric, or harmonic mean of a sample data set, equal importance is assigned to all the data points. However, all the values may not always be equally important in some data sets. An intrinsic bias might make it more important to give more weightage to specific values over others.
For example, consider the number of goals scored in the matches of a tournament. While computing the average number of goals scored in the tournament, it may be more important to...
6.0K
What are Estimates?01:06

What are Estimates?

It isn't easy to measure a parameter such as the mean height or the mean weight of a population. So, we draw samples from the population and calculate the mean height or mean weight of the individuals in the sample. This sample data acts as a representative measure of the population parameter. These sample statistics are known as estimates. 
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such...
7.3K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
536
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
258
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
960